Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1996-03-22
2000-08-01
Park, Hankyel
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
4241981, 4241841, 4242041, 4241991, 514 44, 514 2, C07K 100, A61K 3900, A61K 3912, A01N 3718
Patent
active
060968699
ABSTRACT:
Interleukin-12 (IL-12) or a functional analogue thereof, or a polynucleotide encoding IL-12 or encoding a functional analogue thereof, is used as a therapeutic material or adjuvant in treating papillomavirus-associated lesions e.g. warts due to HPV 6 and/or 11, e.g. condyloma acuminata. IL-12 or a vector encoding it for endogenous production can be used together with a vaccine such as a papillomavirus antigen, or a vector encoding a papillomavirus antigen.
REFERENCES:
patent: 5571515 (1996-11-01), Scott et al.
Friedmann (1997) Scientific American, Jun. 1997, pp. 96-101.
Verma et al. (1997) Nature, vol. 389, pp. 239-242.
Orkin et al. (Dec. 5, 1995) Report and Recommendations of the Panel to Access the NIH Investment in Research on Gene Therapy. issued by The National Institutes of Health.
Eron, L.J., et al., "Interferon Therapy for Condylomata Acuminata," The New England Journal of Medicine, 315(17):1059-1064 (1986).
Chan, S.H., et al., "Induction of Interferon .gamma. Production by Natural Killer Cell Stimulatory Factor: Characterization of the Responder Cells and Synergy with Other Inducers," J. Exp. Med., 173:869-879 (1991).
Afonso, L.C.C., et al., "The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania major," Science, 263:235-237 (1994).
Martinotti, A., et al., "CD4 T Cells Inhibit in vivo the CD8-mediated Immune Response Against Murine Colon Carcinoma Cells Transduced with Interleukin-12 Genes," Eur. J. Immunol., 25:137-146 (1995).
Scarpini, C.G., et al., "Cytokine mRNA Profiles in Genitoanal Warts," 9th International Congress of Immunology, Jul. 23-29, 1995. San Francisco: California. 0(0):370 (1995).
Ausbel et al., "Short Protocols in Molecular Biology," 3rd. Edition (John Wiley & Sons), pp. 8-1 to 8-22 (Oct. 1995).
Zou et al., "Structure-Function Analysis of the p35 Subunit of Mouse Interleukin 12*," Journal of Biological Chemistry, 370(11):5864-5871 (Mar. 17, 1995).
Schoenhaut et al., "Cloning and Expression of Murine IL-12," Journal of Immunology, 148(11):3433-3440 (Jun. 1, 1992).
Wolf et al., "Cloning of cDNA for Natural Killer Cell Stimulatory Factor, and Heterodimeric Cytokine with Multiple Biologic Effects on T and Natural Killer cells," Journal of Immunology, 146(9):3074-3081 (May 1, 1991).
Razin et al., "Efficient correction of a mutation by use of chemically synthesized DNA", Proc. Natl. Acad. Sci. USA, pp. 4268-4270, (1978).
Gillam et al., "Defined transversion mutations at a specific position in DNA using synthetic oligodeoxyribonucleotides as mutagens", Nucleic Acids Res. 6:2973-2985, (1979).
Gillam et al., "Site-Specific Mutagenesis Using Synthetic Oligodeoxyribonucleotide Primers: I", Gene, 8:81-97, (1979).
Gillam et al., "Site-Specific Mutagenesis Using Synthetic Ogligodeoxyribonucleotide Primers: II", Gene 8:99-106, (1979).
Gillam et al., "Site-Specific Mutagenesis using oligodeoxyribonucleotides: isolation of a phenotypically silent phiX174 mutant, with a specific nucleotide deletion, at very high efficiency", Gene 12:129-137, (1980).
Wallace et al., "Directed Deletion of a Yeast Transfer RNA Intervening Sequence", Science 209:1396-1400, (1980).
Wallace et al., "Oligonucleotide directed mutagenesis of the human B-globin gene: a general method for producing specific point mutations in cloned DNA", Nucleic Acids Res. 9:3647-3656, (1981).
Kudo et al., "Site-specific mutagenesis of cloned DNAs: Generation of mutant of E. coli tyrosine suppressor tRNA in which the sequence G-T-T-C corresponding to the universal G-T-.PSI.-C sequence of tRNAs is changed to G-A-T-C", Proc. Natl. Acad. Sci. USA 78:4753-4757, (1981).
Riggs et al., "Synthetic DNA and Medicine", Am. J. Hum. Genet. 31:531-538, (1979).
Simons et al., "Oligonucleotide-directed mutagenesis of gene IX of bacteriophage M13", Nucleic Acids Res. 10:821-832, (1982).
Montell et al., "Resolving the functions of overlapping viral genes by site-specific mutagensis at a mRNA splice site", Nature, 295:380-384, (1982).
Scarpini Cinzia Giuseppina
Stanley Margaret Anne
Cambridge University Technical Services Ltd.
Park Hankyel
LandOfFree
Treatment of papillomavirus-associated lesions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of papillomavirus-associated lesions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of papillomavirus-associated lesions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-665110